Real world experience with pembrolizumab and nivolumab for treatment of non-small cell lung cancer (NSCLC) in an Irish Regional Cancer Center

被引：3
|
作者：
Dennehy, Colum
Mullally, Will
Goggin, Caitriona
Gleeson, Jack Patrick
Greene, John Patrick
Power, Derek Gerard
O'Reilly, Seamus
Collins, Dearbhaile Catherine
O'Mahony, Deirdre
Bambury, Richard Martin
机构：
[1] Cork Univ Hosp, Cork, Ireland
[2] MMUH, Dublin, Ireland
[3] Adelaide & Meath Hosp, Dublin, Ireland
[4] Mercy Univ Hosp, Cork, Ireland
[5] Inst Canc Res, Sutton, Surrey, England
[6] Royal Marsden Hosp, Sutton, Surrey, England
[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[8] Weill Cornell Med Coll, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21196
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21196
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Nivolumab and Pembrolizumab for Non-Small Cell Lung Cancer
    Morgensztern, Daniel
    Herbst, Roy S.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3713 - 3717
  • [2] Real World Experience of First Line Pembrolizumab for Non-Small Cell Lung Cancer (NSCLC) at a Tertiary Centre
    Fletcher, J.
    Mullally, W. J.
    Berman, C.
    Ladwa, R.
    Xu, W.
    O'Byrne, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S628 - S629
  • [3] Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
    Lim, Sun Min
    Kim, Sang-We
    Cho, Byoung Chul
    Kang, Jin Hyung
    Ahn, Myung-Ju
    Kim, Dong-Wan
    Kim, Young-Chul
    Lee, Jin Soo
    Lee, Jong-Seok
    Lee, Sung Yong
    Park, Keon Uk
    An, Ho Jung
    Cho, Eun Kyung
    Jang, Tae Won
    Kim, Bong-Seog
    Kim, Joo-Hang
    Lee, Sung Sook
    Na, Im-Il
    Yoo, Seung Soo
    Lee, Ki Hyeong
    CANCER RESEARCH AND TREATMENT, 2020, 52 (04): : 1112 - 1119
  • [4] Real-world data on nivolumab treatment of non-small cell lung cancer
    Brustugun, O. T.
    Sprauten, M.
    Helland, A.
    ACTA ONCOLOGICA, 2017, 56 (03) : 438 - 440
  • [5] Single-center experience with nivolumab in pretreated patients with non-small cell lung cancer (NSCLC).
    Rapoport, Bernardo Leon
    Smit, Teresa
    van Eeden, Ronwyn
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [6] Real world efficacy of nivolumab for non-small cell lung cancer (NSCLC) in the West of Scotland (WoS)
    Ansel, S.
    Rulach, R.
    Clark, B.
    Steele, N.
    Maclaren, V.
    LUNG CANCER, 2018, 115 : S35 - S36
  • [7] Real World Experience of 1st Line Pembrolizumab in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Ansel, S.
    Mcloone, P.
    Steele, N.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S926 - S926
  • [8] Real-world experience of treatment with afatinib in advanced non-small cell lung cancer (NSCLC) in Vietnam
    Dong, H.
    Tuan, K. Nguyen
    Bui, T. T. P.
    Dong, H.
    ANNALS OF ONCOLOGY, 2022, 33 : S1590 - S1590
  • [9] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): The Real-Life Data
    Dudnik, Elizabeth
    Moskovitz, Mor
    Daher, Sameh
    Shamai, Sivan
    Hanovich, Ekaterina
    Shechtman, Yelena
    Abu-Amna, Mahmoud
    Zer, Alona
    Wollner, Mira
    Bar, Jair
    Merimsky, Ofer
    Cyjon, Arnold
    Shochat, Tzippy
    Peled, Nir
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S417 - S418
  • [10] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): A Real-Life Study
    Reis, D.
    Mendes, A.
    China, N.
    Dias, M.
    Coutinho, D.
    Silva, E.
    Campainha, S.
    Costa, T.
    Conde, S.
    Barroso, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S975 - S976
12345